Ahmed Hamdy
Chief Executive Officer chez VINCERX PHARMA, INC.
Fortune : 9 M $ au 31/03/2024
Profil
Ahmed M.
Hamdy is the founder of Vincerx Pharma, Inc. (founded in 2018) and holds the title of Chairman & Chief Executive Officer.
Dr. Hamdy is also the founder of Acerta Pharma BV, Acerta Pharma LLC.
Dr. Hamdy's current job(s) include being an Independent Director at Andes Biotechnologies SA (since 2016), a Director & Clinical Advisor at Andes Biotechnologies Global, Inc. (since 2016), a Member at AstraZeneca PLC (since 2013), a Member-Presidents Council at The Palo Alto Medical Foundation (since 2016), and a Member-Deans Council at Baskin School of Engineering (since 2019).
Dr. Hamdy's former job(s) include being a Medical Director at ALZA Corp.
(2004-2006), a Medical Director at Johnson & Johnson (2004-2006), a Senior Principal Scientist at Actavis, Inc. (2000-2004), and a Chief Medical Officer at Pharmacyclics LLC (2008-2011).
Dr. Hamdy's education history includes a doctorate from the University of Cairo and an undergraduate degree from KasrAlAiny School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VINCERX PHARMA INC
8,02% | 07/03/2024 | 1 714 259 ( 8,02% ) | 9 M $ | 31/03/2024 |
Postes actifs de Ahmed Hamdy
| Sociétés | Poste | Début |
|---|---|---|
| VINCERX PHARMA, INC. | Chief Executive Officer | 01/03/2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2015 |
Andes Biotechnologies Global, Inc.
 Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA. | Director/Board Member | 01/09/2016 |
| Baskin School of Engineering | Corporate Officer/Principal | 01/04/2019 |
| The Palo Alto Medical Foundation | Corporate Officer/Principal | 01/03/2016 |
Andes Biotechnologies SA
 Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Director/Board Member | 01/09/2016 |
Anciens postes connus de Ahmed Hamdy
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 23/06/2011 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | 01/02/2006 |
| ALZA CORPORATION | Chief Tech/Sci/R&D Officer | 01/02/2006 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░ | - |
Formation de Ahmed Hamdy
| University of Cairo | Doctorate Degree |
| KasrAlAiny School of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| VINCERX PHARMA, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
| The Palo Alto Medical Foundation | Health Services |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Health Technology |
Andes Biotechnologies Global, Inc.
Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA. | Health Technology |
| Acerta Pharma LLC |
